BRCA1/2 mutation carriers whose tumors displayed expression of nFTH1 more frequently had a favorable tumor grade (p = 0.015) as well as positive ER (p = 0.002) and PR status (p = 0.029). Here, BRCA1 is linked to neoplasm.